ARE ACE-INHIBITORS OR ARB’S STILL NEEDED FOR CARDIOVASCULAR PREVENTION IN HIGH RISK PATIENTS? INSIGHTS FROM PROFESS AND TRANSCEND
暂无分享,去创建一个
C. Brohet | L. Pierard | L. Missault | G. Vanhooren | F. Heller | A. Persu | W. van Mieghem | J. Krzesinski | A. Dupont | P. Vervaet | J. Billiouw | M. Gazagnes | R. Rottiers | A. Herman